The gadget enables patients to self-inject TNF inhibitors without the need for measurement or preparation.
The APP-1000, a motorised medication injection device, has been certified by the European Union Medical Devices Regulation (EU-MDR) by PHC's in vitro diagnostics section.
The portable medical device of class IIa is designed to administer anti-inflammatory drugs known as tumour necrosis factor (TNF) inhibitors.
....Tags : European Union, EU-MDR, self-inject TNF inhibitors ,
comments (0)